Similar to other members of the flavivirus genus of togaviruses, such as Japanese encephalitis virus, the dengue viruses, yellow fever virus or St. Louis encephalitis virus, tick-borne encephalitis (TBE) virus is the causative agent of a disease which represents an important public health problem in endemic areas. As shown by virus isolation or serological surveys, TBE virus occurs in most European countries, Russia, and probably also China. In Austria, some hundreds of hospitalized patients suffering from TBE are recorded each year and diagnosis has to depend upon serological tests, due to the lack of specific clinical symptoms. The development of solidphase immunoassays for the selective determination of virus-specific immunoglobulin M (IgM) and IgG antibodies has been a major breakthrough for the rapid serodiagnosis ofvirus infections (3, 17) . In 1978, a radioimmunoassay was developed for the diagnosis of TBE (6) and then an enzyme immunoassay employing the same test principle was established (9) which currently is used for the routine diagnosis of this disease at our institute. Because of the possibility of determiiing antibody activity in different immunoglobulin classes directly, without serum fractionation, and the very high sensitivity of these tests, they have increasingly replaced the conventional, previously used, complement fixation or hemagglutination inhibition tests. The use of enzyme-labeled, instead of radioactively labeled, tracer molecules and the possibility of using inactivated noninfectious antigens make these techniques even more feasible for the routine diagnostic laboratory. As with the above cited immunoassays for TBE virus antibodies, most frequently the antigen is coated to the solid phase and, after reaction with specific antibodies, these are detected by the use of radioactively or enzyme-labeled sera specific for either ,u or y chains of human immunoglobulins. More recently "reverse" solid-phase enzyme immunoassays or radioimmunoassays have been introduced to diagnostic virology, and this principle has been successfully applied to the detection of IgM antibodies against hepatitis A virus (1, 4, 5, 12-15), hepatitis B core antigen (7), rubella virus (10) and also TBE virus (Roggendorf et al., J. Med. Virol., in press). In these tests, ,u-chain-specific antibodies are bound to the solid phase to The influence of these sera in both types of enzyme immunoassay is shown in Fig. 1A and B. When antigen was coated to the solid phase (Fig. 1A) To compare sensitivity of the tests for the detection of IgM antibodies, titration curves of five individual sera were determined in each test (Fig. 2) . These sera were previously shown to be IgM-positive by our routine ELISA procedure (9) as well as by the hemagglutination inhibition test in combination with 2-mercaptoethanol treatment (11) . For measuring absorbance values, the buffer control was taken as zero and the cutoff line for titer determinations was arbitrarily set at 0.1 absorbance unit in each test. The titer of each serum was determined as the recip- VOL. 14, 1981 rocal value of that dilution at which the extension of the linear part of the titration curve crossed the cutoff line. It must, however, be kept in mind that these values are strongly dependent on the slopes of the curves, which may vary from one serum to another due to different avidities for the antigen, and, therefore, only the same individual sera can be compared. Table 1 shows the results of titer determination of the titrations shown in Fig. 2 bND, Not done. Application in routine diagnosis. In 1980, 272 cases of TBE were diagnosed at the Institute of Virology (Vienna) by the demonstration of TBE virus-specific IgM antibodies by using the previously described ELISA system (9) with antigen coated to the solid phase, which was performed identically to the procedure described for test A. In addition to these cases, there were some uncertain cases of meningitis or encephalitis which, according to their history of tick-bite in an endemic area and the presence of high titers of IgG antibodies, also were suspect as being TBE. However, IgM antibodies could be demonstrated reliably neither by the above-mentioned ELISA technique nor by the hemagglutination inhibition test in combination with 2-mercaptoethanol treatment of sera (11) . By the use of the new IgM-capturing assay technique, IgM antibodies could be unequivocally demonstrated in 19 additional cases and, thus, the diagnosis was confirmed despite a high level of specific IgG antibodies. Due to the high sensitivity of the test (Fig. 2 ) it might be sufficient for routine diagnosis of acute cases of TBE to test serum samples at a single dilution of 1:1,000.
RF. When using indirect immunoassays (antigen-coated solid phase), RF may cause falsepositive IgM results in the presence of specific IgG antibodies (13) . As has been reported previously (9), such a reaction occurred only in 1 of about 1,200 sera sent to our laboratory, and, therefore, we had only one such serum available which gave a false-positive reaction in the indirect ELISA due to the presence of RF in addition to specific IgG. No such interference was seen in the IgM-capturing test in which the same serum was clearly shown to contain no IgM antibodies against TBE virus.
When anti-human ,u is coated to the solid phase, IgM containing RF will also be bound, and this could yield false-positive results when the enzyme-labeled antiserum reacts nonspecifically with the bound RF (15) . We therefore tested 24 RF-positive sera at a dilution of 1: 1,000, which would still be suitable for the detection of specific IgM in the diagnosis of TBE (Fig. 2) . Only one of these showed a low falsepositive reaction with an absorbance value of 0.22.
DISCUSSION
We have compared the two different test systems used in enzyme immunoassays for the assay of IgM antibodies against TBE virus; with one we employed a solid phase coated with antigen (test A), and with the other, we employed a solid phase coated with antibodies against ,i chains of human immunoglobulins (test B). When antigen was coated to the solid phase, the specific IgM titer was strongly depressed in the presence of large amounts of specific IgG antibodies due to competition for antibody-binding sites. No such interference could be shown in the IgM-capturing system, and this is extremely valuable for the diagnosis to be established reliably in critical cases when the sera are drawn late after onset of illness and the patients have developed already high titers of IgG antibodies against TBE virus. In 1980, 272 cases were verified as TBE positive by test A. By the application of test B, 19 additional cases of TBE were diagnosed which would have been missed by the assay employing antigencoated solid phase or hemagglutination inhibition in combination with 2-mercaptoethanol treatment (11) . Overall, the IgM capturing assay was more sensitive, resulting in 5-to 200-fold higher titers; its superiority, however, was most prominent when the sample contained high titers of anti-TBE virus IgG. The high sensitivity and lack of interference by specific IgG should also permit this test to be used to investigate local synthesis of IgM antibodies in the brain during TBE and to measure the long term persistence of IgM antibodies in serum and CSF. Persistence of specific IgM for more than 1 year has been reported for severe Japanese encephalitis virus infections (2) , and a long term study to investigate the persistence of IgM antibodies after TBE virus infections has been initiate%.
A major drawback of the test with antigen coated to the solid phase is the danger of falsepositive IgM results when RF is present in addition to specific IgG (13) . In the diagnosis of TBE, the frequency of the combination RF plus TBE virus-specific IgG in sera sent to our laboratory has been estimated to be relatively low, about 1 (18) (19) (20) .
